trending Market Intelligence /marketintelligence/en/news-insights/trending/kzkQKYitNvP9OHhQH3Jr1Q2 content esgSubNav
In This List

Allergan's topical cream for facial redness gets thumbs up from US FDA

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


Allergan's topical cream for facial redness gets thumbs up from US FDA

The U.S. FDA approved Allergan PLC's Rhofade cream for the treatment of persistent facial redness in adults with rosacea, a common long-term skin disease.

Rhofade will be commercially available in the U.S. starting in May.